Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Selecting Patients for AF Ablation in Heart Failure
Author(s): Aaron A Sifuentes , Mohammed Mhanna , Paari Dominic , et al Added: 2 weeks ago

Demographic

Electrophysiology & Arrhythmia
Atrial Cardiomyopathy and AF in Heart Failure Substrates
Author(s): Bharat K Kantharia , Lingling Wu , Mohit M Hulsurkar , et al Added: 2 months ago

Imaging & Diagnostics

Electrophysiology & Arrhythmia
ECAS Guidelines on Catheter Ablation for Atrial Fibrillation
Author(s): Riccardo Cappato , Rui Providencia Added: 1 year ago
What updates do ECAS recommend for catheter ablation of atrial fibrillation?In this short interview, Prof Riccardo Cappato (IRCCS Humanitas Research Hospital, Milan, IT) and Prof Rui Providência (St Bartholomew's Hospital, London, UK) discuss new guidelines released by ECAS on catheter ablation for atrial fibrillation (AF). Prof Cappato and Prof Providência explain the need for an updated and… View more

Electrophysiology & Arrhythmia
Medical Therapy of Heart Failure and AF
Author(s): Gregory Burkman , Gerald V Naccarelli Added: 1 month ago

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
Device-detected AF: How Much is Too Much?
Author(s): Jude Scott Added: 1 month ago

Imaging & Diagnostics

Prevention & Chronic Conditions
HRS 2026: GLP-1 Agonists and AF Risk Beyond Weight Loss
Author(s): Kenneth Bilchick Added: 1 month ago
HRS Congress 2026 — Dr Kenneth Bilchick (UVA Heart & Vascular Center, Charlottesville, VA, US) joins us to discuss findings from a study examining whether the protective effect of glucagon-like peptide-1 (GLP-1) receptor agonists on atrial fibrillation risk operates independently of weight loss and survival.Interview Questions:What is the current understanding of how GLP-1 receptor agonists may… View more

Cardiovascular Kidney Metabolic
ESC 24: The GUARD-AF Trial
Author(s): Renato D Lopes Added: 1 year ago
ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.We are joined onsite at ESC Congress 2024 by Dr Renato Lopes (Duke University Medical Center, NC) to discuss the findings from the GUARD-AF Trial (NCT04126486, Bristol-Myers Squibb), which was designed to determine if screening for undiagnosed… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
ESC 24 Hot Line Discussion: The OCEANIC-AF Trial
Author(s): Manesh R Patel , Harriette Van Spall Added: 1 year ago
ESC Congress 2024 — OCEANIC-AF was halted early due to a lack of efficacy in 2023. Investigators shared details of the trial at ESC, comparing asundexian against apixaban in patients with atrial fibrillation at risk of stroke.Host Dr Harriette Van Spall (McMaster University, Hamilton, Canada) sits down with primary investigator Dr Manesh R Patel (Duke University Health System, USA) to discuss the… View more

Anticoagulation

Electrophysiology & Arrhythmia
HRS 24: Tailored Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation: TAILORED-AF
Author(s): Isabel Deisenhofer Added: 2 years ago
HRS 2024 — Prof Isabel Deisenhofer (German Heart Center Munich, Technical University of Munich, DE), investigator, joins us to discuss the findings from the TAILORED-AF trial (NCT04702451, Volta Medical).This randomised controlled trial compared a tailored ablation strategy targeting areas of patio-temporal dispersion in combination with pulmonary vein isolation (PVI) to anatomical ablation… View more

Electrophysiology & Arrhythmia